Afya Limited (NASDAQ:AFYA - Get Free Report)'s share price gapped up prior to trading on Friday . The stock had previously closed at $16.22, but opened at $17.90. Afya shares last traded at $18.39, with a volume of 50,822 shares trading hands.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Morgan Stanley lowered shares of Afya from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $19.00 to $17.00 in a research note on Tuesday, March 11th. JPMorgan Chase & Co. decreased their target price on shares of Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research report on Friday, January 17th. Citigroup reissued a "sell" rating and issued a $15.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 31st. Finally, The Goldman Sachs Group began coverage on shares of Afya in a research report on Tuesday, December 3rd. They issued a "sell" rating and a $16.00 target price for the company. Three research analysts have rated the stock with a sell rating and two have issued a hold rating to the stock. According to data from MarketBeat, Afya currently has an average rating of "Reduce" and a consensus target price of $17.60.
Read Our Latest Analysis on AFYA
Afya Trading Up 0.3 %
The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. The company's fifty day moving average is $16.54 and its 200-day moving average is $16.45. The firm has a market capitalization of $1.69 billion, a P/E ratio of 14.52, a P/E/G ratio of 0.29 and a beta of 0.82.
Institutional Trading of Afya
Hedge funds have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio bought a new stake in Afya in the 3rd quarter valued at $34,000. Blue Trust Inc. raised its stake in shares of Afya by 296.9% in the 4th quarter. Blue Trust Inc. now owns 2,072 shares of the company's stock valued at $35,000 after buying an additional 1,550 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Afya by 1,099.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock valued at $64,000 after buying an additional 3,695 shares in the last quarter. Quarry LP acquired a new position in shares of Afya in the 3rd quarter valued at $75,000. Finally, JPMorgan Chase & Co. raised its stake in shares of Afya by 2,115.9% in the 4th quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after buying an additional 6,369 shares in the last quarter. 88.02% of the stock is owned by institutional investors.
Afya Company Profile
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
